Compare Twist Bioscience Corp (TWST) vs United States Oil ETF (USO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Twist Bioscience Corp vs United States Oil ETF — how do they compare? Twist Bioscience Corp trades at $152.84 (market cap $10.08B), while United States Oil ETF trades at $147.13 (market cap $1.90B). The key difference: Twist Bioscience Corp is far larger — about 5.3× United States Oil ETF's market cap, and United States Oil ETF is trading nearer its 52-week high, Twist Bioscience Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Twist Bioscience Corp for 27 Days and United States Oil ETF for 21 Days on average.
| TWST | USO | |
|---|---|---|
Market Cap | $10.08B | $1.90B |
Volume | 4,229,037 | 5,932,922 |
Sector | Health | — |
52-Week High | $205.00 | $161.86 |
52-Week Low | $25.45 | $66.17 |
Typical Hold Time | 27 Days | 21 Days |
Enterprise Value | $10.01B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TWST trades at $155.65, down 6.78% today, reflecting a bearish technical signal and recent earnings misses. Revenue growth is strong, rising to $376.57M in 2025, but profitability remains elusive with a net income margin of -31.66%. The company's partnership with Lilly TuneLab for AI-driven drug discovery has generated positive news flow, yet cash flow remains negative, and the stock trades at elevated valuation multiples like P/S of 22.01.
The outlook is mixed: strong analyst buy-side consensus (73% Buy) and strategic AI partnerships offer growth potential, but persistent losses, high cash burn, and bearish technicals pose significant risks. Investors face a trade-off between long-term innovation prospects and near-term financial instability.
USO trades at $143.91, down 0.7% amid mixed oil market signals. Technical indicators show neutral sentiment with bearish moving averages, while support levels cluster around $140-142. Recent news highlights Middle East tensions and OPEC+ production decisions creating supply uncertainty. The stock faces headwinds from coordinated G-7 reserve releases but benefits from geopolitical risk premiums.
Outlook remains balanced with technical support providing downside protection while geopolitical risks and supply dynamics drive volatility. Investment opportunity exists for traders capitalizing on oil price swings, though fundamental data limitations require careful risk management given the commodity-sensitive nature of this energy-focused security.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →About United States Oil ETF
This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →
